Compare PRCT & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRCT | AZTA |
|---|---|---|
| Founded | 2009 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2021 | 1995 |
| Metric | PRCT | AZTA |
|---|---|---|
| Price | $34.66 | $37.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $51.13 | $44.25 |
| AVG Volume (30 Days) | ★ 1.2M | 714.3K |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $299,907,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $48.30 | $6.13 |
| Revenue Next Year | $29.44 | $5.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 50.07 | 3.55 |
| 52 Week Low | $27.80 | $23.91 |
| 52 Week High | $89.30 | $55.64 |
| Indicator | PRCT | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 56.17 | 64.50 |
| Support Level | $30.60 | $32.94 |
| Resistance Level | $35.40 | $37.93 |
| Average True Range (ATR) | 1.44 | 1.04 |
| MACD | 0.13 | 0.22 |
| Stochastic Oscillator | 83.75 | 87.68 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.